Atlas Trials

The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma

Clinical trial NCT02449278 · UNKNOWN

Trial details

NCT number
NCT02449278
Sponsor
Wuhan University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2015-10-01
Primary completion
2019-10-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.